Galderma stock pre-market at EUR 189.30: dermatology group
Published on 10/21/2026 at 08:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSDermatology portfolio and market context
- Galderma develops products and services across injectable aesthetics, dermatological skincare and therapeutic dermatology.
- Market context is the SMI benchmark for Switzerland.
- Galderma stock trades pre-market at EUR 189.30 at 8:37 a.m. CEST at Lang & Schwarz on October 21, 2026.
Galderma develops products and services across injectable aesthetics, dermatological skincare and therapeutic dermatology, according to a company release distributed by Business Wire. The company operates across the dermatology market.
Ahead of the Xetra open
Lang & Schwarz records the pre-market indication for the October 21, 2026 session. The opening phase provides the first euro-market reference for the German trading day, while the primary listing is on SIX Swiss Exchange under the symbol GALD. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Galderma stock.
Galderma's business and today's context
Galderma earns revenue from a portfolio spanning injectable aesthetics, dermatological skincare and therapeutic dermatology, serving consumers, patients and healthcare professionals in the dermatology market, as described by Galderma. The relevant benchmark context for the Swiss home market is the SMI.
Market context: Market report SMI.
